Metabolic Disorders: The Hidden Link to Cognitive Health

Introduction

Ornithinemia is a rare and often misdiagnosed inherited metabolic disorder caused by a defect in the enzyme ornithine transcarbamylase (OTC). It is an X-linked disorder, meaning that it is passed along through the X chromosome from mother to son, and can affect both males and females. Symptoms can range from mild to severe and may include developmental delays, behavior issues, sleep disturbances, seizures, vomiting, mental retardation, and failure to thrive. The main treatment is dietary management and supplementation with certain amino acids.

Pathophysiology

Ornithinemia is caused by a deficiency of the enzyme ornithine transcarbamylase (OTC). This enzyme is responsible for the conversion of ornithine into citrulline and is found in the urea cycle. A defect in OTC results in the buildup of ornithine and other related compounds in the blood, which can lead to a variety of symptoms.

Signs and Symptoms

The symptoms of ornithinemia vary depending on the severity of the disorder and can range from mild to severe. Common symptoms include developmental delays, behavior issues, sleep disturbances, seizures, vomiting, mental retardation, and failure to thrive. In more severe cases, the disorder can lead to liver and kidney failure, coma, and even death.

Diagnosis and Treatment

The diagnosis of ornithinemia is based on the clinical presentation and laboratory tests which measure the levels of ornithine and other related compounds in the blood. Treatment is aimed at managing the symptoms and involves dietary management and supplementation with certain amino acids.

Conclusion

Ornithinemia is a rare and often misdiagnosed metabolic disorder caused by a defect in the enzyme ornithine transcarbamylase (OTC). Symptoms can be mild to severe and may include developmental delays, behavior issues, sleep disturbances, seizures, vomiting, mental retardation, and failure to thrive. The diagnosis is based on clinical presentation and laboratory tests, and treatment involves dietary management and supplementation with certain amino acids.

References

Barańska, A., & Dąbrowska, A. (2020). Ornithinemia: Phenotype, laboratory diagnostics, and treatment. Orphanet Journal of Rare Diseases, 15(1), 191. https://doi.org/10.1186/s13023-020-1427-z

Liang, C., Lin, L., & Huang, Y. (2019). Ornithinemia. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK441936/

Maranda, B., & Keppler, D. (2008). Ornithinemia: A rare metabolic disorder with severe neurological symptoms. Molecular Genetics and Metabolism, 93(3), 221–226. https://doi.org/10.1016/j.ymgme.2007.11.003